The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharacter Regulatory News (CCT)

Share Price Information for Character (CCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 293.00
Bid: 290.00
Ask: 296.00
Change: 1.00 (0.34%)
Spread: 6.00 (2.069%)
Open: 293.00
High: 294.00
Low: 293.00
Prev. Close: 293.00
CCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Option & Trading Update

26 Jul 2010 07:00

RNS Number : 8803P
Character Group PLC
26 July 2010
 



 

Issued by Citigate Dewe Rogerson Ltd, Birmingham

Date: Monday, 26 July 2010

Embargoed: 7.00am

Grant of Option to purchase ordinary shares in

The Character Group

and

Trading update

 

In recognition of the working partnership with Cepia, LLC ("Cepia") the Board of The Character Group plc ("Character" or "the Group") has today agreed to grant an option ("Option") to Cepia HK Limited, a subsidiary of Cepia, to subscribe for the issue of up to a maximum of 1,000,000 Ordinary shares in Character, representing approximately 3.79% of the current issued share capital of Character (excluding shares held in treasury) at an option price of 122.5 pence per share, being the mid market price of the issued ordinary shares in Character at the close of business on 23 July 2010.

 

The Option is exercisable by Cepia in the period between the third and fifth anniversaries of the date of grant of the Option (i.e. 23 July 2013 and 23 July 2015), subject, inter alia, to the continuation of the exclusive distribution relationship between Character and Cepia for at least the next four years

 

Cepia, which has a long history of supplying the Character Group companies with unique and innovative products, has created certain Intellectual Property Rights, including that of the ZhuZhu brand which includes ZhuZhu Pets (formerly branded GoGo pets in the UK); Character is the exclusive distributor for these and related products in the UK and Eire.

 

Commenting on the Option grant, Richard King Chairman at Character Group said:

 

"We believe, as a Board, that this arrangement recognises the close relationship between Cepia and Character. Together we have had tremendous success with the ZhuZhu brand and we believe that this will continue as new and exciting products are developed and introduced into the UK and Eire markets."

 

Although the environment remains tough for the High street and Character faces the same challenges as its competitors, the Group continues to develop its portfolio of branded products and build its market share in the UK.

 

The Directors are confident that trading for the financial year ending 31 August 2010 will at least meet market expectations.

 

Enquiries:

Richard King, Chairman

Fiona Tooley

Kiran Shah, Group Finance Director & Joint MD

Keith Gabriel

The Character Group plc

Citigate Dewe Rogerson

Mobile: +44 (0)7836 250150 (RK)

Mobile: +44 (0)7785 703523 (FT)

Mobile: +44 (0)7956 278522 (KS)

Tel: +44 (0)121 362 4035

Tel: +44 (0)208 329 3377

www.thecharacter.com

Ticker: AIM: CCT

 

Dugald J. Carlean

Russell Cook

Carl Holmes

Charles Stanley Securities

(Nominated Adviser)

Tel: +44 (0)207 149 6000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUVUWRRUABUAR
Date   Source Headline
10th May 20245:33 pmRNSTransaction in Own Shares
9th May 20247:00 amRNSHalf-Year Financial Report - six months to 29.2.24
8th May 20245:36 pmRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
2nd May 20244:45 pmRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
29th Apr 20245:47 pmRNSTransaction in Own Shares
26th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20246:16 pmRNSTransaction in Own Shares
11th Apr 20245:23 pmRNSTransaction in Own Shares
9th Apr 20245:25 pmRNSTransaction in Own Shares
8th Apr 20245:49 pmRNSTransaction in Own Shares
4th Apr 20245:44 pmRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSExtension of & increase to Share Buyback Programme
13th Mar 20245:19 pmRNSTransaction in Own Shares
7th Mar 20245:55 pmRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20245:03 pmRNSTransaction in Own Shares
27th Feb 20245:03 pmRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20245:20 pmRNSTransaction in Own Shares
22nd Feb 20245:59 pmRNSTransaction in Own Shares
21st Feb 20245:03 pmRNSTransaction in Own Shares
19th Feb 20246:08 pmRNSTransaction in Own Shares
19th Feb 202412:07 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:13 pmRNSTransaction in Own Shares
14th Feb 20245:38 pmRNSTransaction in Own Shares
13th Feb 20245:49 pmRNSTransaction in Own Shares
9th Feb 20244:19 pmRNSTransaction in Own Shares
8th Feb 20245:44 pmRNSTransaction in Own Shares
7th Feb 202410:20 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSShare Buyback Programme
19th Jan 20244:41 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement - Trading Update
14th Dec 202312:53 pmRNSHolding(s) in Company
14th Dec 202312:49 pmRNSHolding(s) in Company
12th Dec 20237:01 amRNSFinal Results - year ended 31 August 2023
12th Dec 20237:00 amRNSBoard Changes
23rd Oct 20234:58 pmRNSDirector/PDMR Shareholding
3rd Oct 20237:00 amRNSTrading Update
22nd Sep 20234:08 pmRNSHolding(s) in Company
20th Sep 20235:30 pmRNSHolding(s) in Company
22nd Aug 20237:00 amRNSHolding(s) in Company
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
17th May 202311:32 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSHolding(s) in Company
11th May 20237:00 amRNSHalf-year Report - six months to 28 February 2023
27th Mar 20236:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.